Humanoid robots have spent years as a punchline, stumbling across stages at tech conferences while executives promised a revolution that kept not quite arriving. Unitree Robotics would like to change the conversation, and it plans to do so with a $904 million IPO on China’s A-share market.
The Hangzhou-based company has priced its offering at 150.80 yuan per share, targeting a raise of approximately 6.1 billion yuan. If the listing proceeds as planned, Unitree will become the first embodied-intelligence company to trade on the A-share market.
From dog-like bots to the global humanoid leader
CEO Wang Xingxing founded the company in 2016 with a focus on quadrupedal robots. Around 2023 and 2024, the company pivoted toward humanoid designs. In 2025, Unitree shipped over 5,500 humanoid robots, a figure that placed it at the top of the global rankings for the segment. Revenue grew 335% year-over-year.
The company now employs over 1,000 people.
The IPO mechanics and what the money funds
Citic Securities is handling the offering. The bank projects a post-IPO valuation for Unitree in the range of 50.6 to 55.9 billion yuan within six to twelve months of listing, which translates to roughly $7.4 to $8.3 billion at current exchange rates.
Unitree originally targeted a raise of around 4.2 billion yuan before revising the figure upward to 6.1 billion yuan. The proceeds are earmarked across three main categories: research and development, manufacturing capacity expansion, and continued advancement of humanoid robotics technology.
A price inquiry is scheduled for August 6, 2026, with the formal listing expected shortly after.
Why Beijing’s backing matters for the listing
Beijing has been deliberately supportive of tech listings, particularly in sectors it considers strategically important, and humanoid robotics sits near the top of that list alongside artificial intelligence and advanced manufacturing. China’s government has framed humanoid robots as a core part of its industrial upgrade agenda.
The A-share market listing brings retail Chinese investors directly into the humanoid robotics story, putting shares within reach of domestic savers.
What investors should watch
Humanoid robots are still largely in early commercial deployment. Customers are buying them for warehouses, manufacturing lines, and research environments, not yet in the mass-market volumes that would justify the largest valuations.
The IPO also sets a valuation benchmark for the broader sector. If Unitree prices well and trades up, it validates the investment theses of dozens of funds that have poured capital into humanoid robotics over the past three years.